Jefferies Financial Group Inc. Fortress Biotech, Inc. Transaction History

Jefferies Financial Group Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.65 - $1.1 $942,500 - $1.6 Million	-1,450,000 Reduced 33.72%	2,850,000 $2.34 Million
Q4 2022 Sep 21, 2023	BUY	$0.48 - $0.88 $2.06 Million - $3.78 Million	4,300,000 New	4,300,000 $2.84 Million
Q4 2022 Feb 14, 2023	BUY	$0.48 - $0.88 $2.06 Million - $3.78 Million	4,300,000 New	4,300,000 $2.84 Million

1.01M

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $194M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.